Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® Pharmaceutical Investing
Life Science Big News Roundup: Avricore Health Announces New Appointments; Cardiol Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation; PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program Life Science Investing
Ocular Therapeutix™ Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® Biotech Investing
